HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatitis E

Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.
Also Known As:
ET-NANBH; Enterically Transmitted Non A, Non B Hepatitis; Epidemic Non A, Non B Hepatitis; Hepatitides, Water-Borne; Hepatitis, Water Borne; Water-Borne Hepatitides; Water-Borne Hepatitis; Enterically-Transmitted Non-A, Non-B Hepatitis; Epidemic Non-A, Non-B Hepatitis; Hepatitis, Viral, Non-A, Non-B, Enterically-Transmitted; Hepatitis, Water-Borne
Networked: 963 relevant articles (42 outcomes, 95 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infections
2. Virus Diseases (Viral Diseases)
3. Hepatitis C
4. Chronic Hepatitis B
5. Acute Liver Failure (Fulminant Hepatic Failure)

Experts

1. Zhang, Jun: 42 articles (12/2021 - 02/2003)
2. Okamoto, Hiroaki: 27 articles (05/2021 - 02/2003)
3. Xia, Ningshao: 22 articles (01/2020 - 02/2003)
4. Xia, Ning-Shao: 20 articles (12/2021 - 03/2004)
5. Wu, Ting: 17 articles (12/2021 - 05/2007)
6. Aggarwal, Rakesh: 16 articles (05/2021 - 07/2002)
7. Takahashi, Masaharu: 15 articles (05/2021 - 02/2003)
8. Pischke, Sven: 14 articles (12/2022 - 01/2011)
9. Li, Shaowei: 13 articles (01/2020 - 01/2015)
10. Zhao, Qinjian: 13 articles (01/2020 - 06/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hepatitis E:
1. VaccinesIBA
2. Ribavirin (Virazole)FDA LinkGeneric
3. AntigensIBA
4. Hepatitis B e AntigensIBA
5. Antiviral Agents (Antivirals)IBA
6. hecolinIBA
7. RNA (Ribonucleic Acid)IBA
8. Immunoglobulin M (IgM)IBA
9. AntibodiesIBA
10. DNA (Deoxyribonucleic Acid)IBA
12/01/2002 - ": The feasibility of DNA vaccination against hepatitis E in non-human primates has not been evaluated. "
03/01/2001 - "In response to a small antigenic challenge delivered as DNA, possibly less than delivered by a human infective dose of virus, mice with memory were able to generate high levels of antibody in less time than the usual incubation period of hepatitis E. "
12/01/2006 - "To compare the influence of hepatitis E virus (HEV) infection on the replication of hepatitis B virus (HBV) by observing clinical features, the relationship between the number of HBV DNA copies in serum, the degree of hepatic function impairments and prognosis of chronic hepatitis B patients with hepatitis E superinfection. "
04/01/2000 - "TTV-DNA was detected in the following proportions: hepatitis B, 13.2% (7/53); hepatitis C, 16.6% (4/24); hepatitis A, 4.7% (1/21); hepatitis E 20% (1/5). "
03/01/2002 - "The positive rates of TTV ORF1 DNA, ORF2 DNA and the antibody in various populations were as follows: 16.0% (12/75), 10.7% (8/75) and 25.3% (19/75) in paid blood donors; 10.0 (3/30), 16.7% (5/30) and 16.7% (5/30) in patients with hepatitis A, 47.5% (19/40), 42.5% (17/40) and 22.5% (9/40) in patients with hepatitis B; 42.9% (15/35), 37.1% (13/35) and 28.6% (10/35) in patients with hepatitis C; 20.0% (3/15), 26.7% (4/15) and 13.3% (2/15)in patients with hepatitis D; 16.7% (2/12),16.7% (2/12) and 33.3% (4/12)in patients with hepatitis E; 23.8% (5/21), 38.1% (8/21) and 23.8% (5/21) in patients with hepatitis G; 61.1% (11/18), 50.0% (9/18) and 44.4% (8/18) in patients with non A-G hepatitis, respectively. "

Therapies and Procedures

1. Therapeutics
2. Organ Transplantation
3. Transplantation
4. Renal Dialysis (Hemodialysis)
5. Liver Transplantation